NZ721522A - Methods of treating cancer using pd-l1 axis binding antagonists and vegf antagonists - Google Patents

Methods of treating cancer using pd-l1 axis binding antagonists and vegf antagonists

Info

Publication number
NZ721522A
NZ721522A NZ721522A NZ72152213A NZ721522A NZ 721522 A NZ721522 A NZ 721522A NZ 721522 A NZ721522 A NZ 721522A NZ 72152213 A NZ72152213 A NZ 72152213A NZ 721522 A NZ721522 A NZ 721522A
Authority
NZ
New Zealand
Prior art keywords
antagonists
methods
axis binding
treating cancer
vegf
Prior art date
Application number
NZ721522A
Inventor
Heather Maecker
Bryan Irving
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NZ721522A publication Critical patent/NZ721522A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention describes combination treatment comprising a PD-1 axis binding antagonist, oxaliplatin, leucovorin and 5-FU, and optionally a VEGF antagonist, and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired, such as increasing tumor immunogenicity for the treatment of cancer.
NZ721522A 2012-05-31 2013-05-30 Methods of treating cancer using pd-l1 axis binding antagonists and vegf antagonists NZ721522A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261653861P 2012-05-31 2012-05-31
NZ70278213 2013-05-30

Publications (1)

Publication Number Publication Date
NZ721522A true NZ721522A (en) 2018-03-23

Family

ID=61626678

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ721522A NZ721522A (en) 2012-05-31 2013-05-30 Methods of treating cancer using pd-l1 axis binding antagonists and vegf antagonists

Country Status (1)

Country Link
NZ (1) NZ721522A (en)

Similar Documents

Publication Publication Date Title
MX2019003942A (en) Methods of treating cancer using pd-l1 axis binding antagonists and vegf antagonists.
ZA202110554B (en) Methods of treating cancer using pd-1 axis binding antagonists and tigit inhibitors
PH12018500365A1 (en) Methods of treating cancer using pd-1 axis binding antagonists and mek inhibitors
MX2016007885A (en) Methods of treating cancer using pd-1 axis binding antagonists and an anti-cd20 antibody.
ZA201806633B (en) Reducing tumor burden by administering ccr1 antagonists in combination with pd-1 inhibitors or pd-l1 inhibitors
HK1252149A1 (en) Compositions and methods for identification, assessment prevention, and treatment of cancer using pd-l1 isoforms
MX2017000546A (en) Compositions for treating cancer using pd-1 axis binding antagonists and mek inhibitors.
HK1248608A1 (en) Combinations of liposomal irinotecan, 5-fu and leucovorin for the treatment of pancreatic cancer
IL250187A0 (en) Combination of a pd-1 antagonist and a listeria-based vaccine for treating prostate cancer
NZ718190A (en) Substituted quinazolines for inhibiting kinase activity
MX2019013808A (en) Compounds for treatment of cancer.
CA2908957C (en) Combination therapy comprising a dihydropyrazino-pyrazine compound and an androgen receptor antagonist for treating prostate cancer
IL247586A0 (en) Use of eribulin and mtor inhibitors as combination therapy for the treatment of cancer
IL246880B (en) A combination of oxalipatin, leucovorin and 5- fluorouracil for treating cancer
WO2013106460A3 (en) Compositions and methods for treating malignant astrocytomas
NZ721522A (en) Methods of treating cancer using pd-l1 axis binding antagonists and vegf antagonists
PL3010508T3 (en) Combination of ro5503781, capecitabine and oxaliplatin for cancer therapy

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2020 BY THOMSON REUTERS

Effective date: 20190417

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2021 BY THOMSON REUTERS

Effective date: 20200417

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2022 BY THOMSON REUTERS

Effective date: 20210403

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2023 BY THOMSON REUTERS

Effective date: 20220402

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 30 MAY 2024 BY THOMSON REUTERS

Effective date: 20230403